<DOC>
	<DOCNO>NCT00321009</DOCNO>
	<brief_summary>To prospectively evaluate utility enoxaparin vs. oral warfarin reduction echocardiographic index LV mural thrombus . The primary outcome presence LV mural thrombus 3.5 month . The secondary outcome cost analysis compare two arm .</brief_summary>
	<brief_title>LV Thrombus Pilot Study Comparing Enoxaparin Vs. Warfarin</brief_title>
	<detailed_description>Patients anterior Q-wave MIs ejection fraction &lt; =40 % enrol within first 4 day infarction . Patients randomize receive either enoxaparin 1mg/kg ( maximum 100mg ) subcutaneously every 12 hour one month heparin follow oral warfarin 3 month . Clinical safety evaluation , 2-D echocardiogram baseline 3.5 month cost analysis perform .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Anterior Wall Myocardial Infarction</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Age 18 80 Anterior myocardial infarction : 1 . Pathological Qwaves least 3 contiguous anterior precordial lead , assume new 2 . CK peak &gt; 5 time upper limit normal positive MB band Ejection fraction &lt; =40 % anterior dyskinesis document LV Thrombus MI onset &lt; 7 day randomization Inability give write informed consent Medical condition would prohibit discharge within 48 hour exception need anticoagulation Cardiogenic shock , rest angina unresponsive medical therapy serious ventricular arrhythmia 24 hour prior randomization Patients schedule surgical procedure next 4 month would prevent use enoxaparin warfarin Anemia : Baseline Hgb &lt; =9 gm woman , &lt; =10 gm men platelet count &lt; 100,000 Renal insufficiency ( creatinine &gt; 2.0 mg/dl ) Serious liver disease reflect INR &gt; 1.3 Stroke within past 6 month prior document intracranial subarachnoid hemorrhage Active bleeding major surgery within 2 week prohibit use anticoagulant Acute pericarditis Women childbearing potential unless pregnancy test negative Cardiac noncardiac condition expect survival &lt; 6 month Severe peripheral vascular disease Patients undergo cardiac surgery , include CABG , result index myocardial infarction Allergy aspirin , heparin warfarin , pork pork product History recurrent thromboembolic disease history Protein C , Protein S , antithrombin III deficiency know bleed disorder . Current use warfarin need chronic anticoagulation Current participation trial use investigational drug device Prior enrollment trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Left Ventricular Mural Thrombus</keyword>
	<keyword>Low Molecular Weight Heparin</keyword>
	<keyword>Enoxaparin</keyword>
	<keyword>Warfarin</keyword>
	<keyword>Echocardiograms</keyword>
</DOC>